WASHINGTON, Nov 15 (Reuters) - Data on Veridex LLC’s lab test to quickly detect breast cancer that has spread to lymph nodes lacks long-term information on survival, U.S. regulatory staff said in documents released on Wednesday.
WASHINGTON, Nov 15 (Reuters) - Data on Veridex LLC’s lab test to quickly detect breast cancer that has spread to lymph nodes lacks long-term information on survival, U.S. regulatory staff said in documents released on Wednesday.
